Discovery of 5-Hydroxy-1,4-naphthoquinone (Juglone) Derivatives as Dual Effective Agents Targeting Platelet-Cancer Interplay through Protein Disulfide Isomerase Inhibition
作者:Yu-Pu Juang、Ju-Ying Tsai、Wan-Lan Gu、Hui-Ching Hsu、Chao-Lung Lin、Chin-Chung Wu、Pi-Hui Liang
DOI:10.1021/acs.jmedchem.3c02107
日期:2024.3.14
In this study, a series of 2- and/or 3-substituted juglone derivatives were designed and synthesized. Among them, 9, 18, 22, 30, and 31 showed stronger inhibition activity against cell surface PDI or recombinant PDI and higher inhibitory effects on U46619- and/or collagen-induced platelet aggregation than juglone. The glycosylated derivatives 18 and 22 showed improved selectivity for inhibiting the
在本研究中,设计并合成了一系列2-和/或3-取代的胡桃酮衍生物。其中, 9、18、22、30和31比胡桃醌表现出更强的对细胞表面PDI或重组PDI的抑制活性以及对U46619和/或胶原诱导的血小板聚集的更高的抑制作用。糖基化衍生物18和22显示出改善的抑制多发性骨髓瘤RPMI 8226细胞增殖的选择性,并且在72小时细胞活力测试中IC 50值分别达到61和48nM。此外, 18和22能够阻止肿瘤细胞诱导的血小板聚集和血小板增强的肿瘤细胞增殖。分子对接显示氨基酸残基 Gln243、Phe440 和 Leu443 对于化合物-蛋白质相互作用很重要。我们的结果揭示了胡桃醌衍生物作为新型抗血小板和抗癌双重药物的潜力,它们可通过与 PDI 催化活性位点共价结合来中断血小板与癌症的相互作用。